LINC01703: A Potential Drug Target and Biomarker (G105373113)

Target Name: LINC01703

NCBI ID: G105373113

LINC01703

Other Name(s): Long intergenic non-protein coding RNA 1703 | long intergenic non-protein coding RNA 1703 | lncPARP1

LINC01703: A Potential Drug Target and Biomarker

Long intergenic non-protein coding RNAs (lncNPs) have been identified as a class of non-coding RNAs that play critical roles in various cellular processes. One such lncNP, LINC01703, has shown promise as a potential drug target and biomarker.

LINC01703 is a 22.8 kb RNA molecule that is located between the 5' and 3' ends of the genes encoding proteins. It is encoded by an open reading frame (ORF) consisting of 1,112 nucleotides. LINC01703 plays an important role in the regulation of gene expression, RNA-binding proteins (RBPs) and maintenance of chromatin structure.

RNA-binding proteins are complex proteins that bind to DNA and play a role in the regulation of gene expression. LINC01703 is an RBP known to bind to a variety of RNAs, including miRNA, siRNA, and long non-coding RNAs (lncNPs).

miRNA is a type of RNA molecule with a length of approximately 20-22nt, consisting of a group of molecules called miRNA. miRNA plays an important role in gene expression regulation, cell cycle regulation, apoptosis and immune response. siRNA is also a non-coding RNA molecule, similar to miRNA, but can remove foreign DNA sequences, thereby inhibiting the translation of miRNA.

The interaction and expression patterns of LINC01703 suggest that it may be involved in the regulation of gene expression by miRNAs and siRNAs. Some studies have shown that LINC01703 can serve as a target for miRNA and siRNA, and these RNA molecules can regulate gene expression by binding to LINC01703.

In addition, LINC01703 can also serve as a potential drug target for certain diseases. Some studies have shown that the expression level of LINC01703 can reflect the severity of certain diseases, such as lung cancer, liver cancer, and colon cancer. Therefore, LINC01703 is considered a potential drug target.

LINC01703 can also be used as a potential biomarker. Some studies have shown that the expression level of LINC01703 can be used as a predictor of certain diseases, such as lung cancer, liver cancer, and colon cancer. In addition, the expression level of LINC01703 can also be used as a monitoring indicator of the therapeutic effect of certain diseases.

In summary, LINC01703 is a potential drug target and biomarker. Through further research, its role in gene expression regulation, RNA-binding proteins and diseases can be better understood, and new ideas and methods can be provided for the treatment of diseases.

Protein Name: Long Intergenic Non-protein Coding RNA 1703

The "LINC01703 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01703 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets